nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ADRA2A—epilepsy syndrome	0.133	0.378	CbGaD
Doxazosin—CYP2C19—epilepsy syndrome	0.096	0.274	CbGaD
Doxazosin—CYP2D6—epilepsy syndrome	0.0712	0.203	CbGaD
Doxazosin—ABCB1—epilepsy syndrome	0.0508	0.145	CbGaD
Doxazosin—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0229	0.0736	CbGbCtD
Doxazosin—CYP2C19—Felbamate—epilepsy syndrome	0.0213	0.0684	CbGbCtD
Doxazosin—CYP2C19—Trimethadione—epilepsy syndrome	0.0213	0.0684	CbGbCtD
Doxazosin—ABCB1—Levetiracetam—epilepsy syndrome	0.0202	0.0649	CbGbCtD
Doxazosin—CYP2C19—Fosphenytoin—epilepsy syndrome	0.02	0.0643	CbGbCtD
Doxazosin—CYP2C19—Clobazam—epilepsy syndrome	0.0173	0.0558	CbGbCtD
Doxazosin—CYP2C19—Carbamazepine—epilepsy syndrome	0.0144	0.0462	CbGbCtD
Doxazosin—ABCB1—Clobazam—epilepsy syndrome	0.014	0.045	CbGbCtD
Doxazosin—ABCB1—Lamotrigine—epilepsy syndrome	0.0135	0.0433	CbGbCtD
Doxazosin—CYP2C19—Primidone—epilepsy syndrome	0.0134	0.0432	CbGbCtD
Doxazosin—CYP2C19—Phenytoin—epilepsy syndrome	0.0129	0.0415	CbGbCtD
Doxazosin—CYP2C19—Propofol—epilepsy syndrome	0.012	0.0387	CbGbCtD
Doxazosin—ABCB1—Carbamazepine—epilepsy syndrome	0.0116	0.0373	CbGbCtD
Doxazosin—CYP2C19—Phenobarbital—epilepsy syndrome	0.0115	0.037	CbGbCtD
Doxazosin—CYP2C19—Diazepam—epilepsy syndrome	0.0109	0.035	CbGbCtD
Doxazosin—CYP2C19—Zonisamide—epilepsy syndrome	0.0106	0.0342	CbGbCtD
Doxazosin—ABCB1—Phenytoin—epilepsy syndrome	0.0104	0.0335	CbGbCtD
Doxazosin—ABCB1—Phenobarbital—epilepsy syndrome	0.00927	0.0298	CbGbCtD
Doxazosin—ABCB1—Midazolam—epilepsy syndrome	0.00914	0.0294	CbGbCtD
Doxazosin—CYP2D6—Propofol—epilepsy syndrome	0.00914	0.0294	CbGbCtD
Doxazosin—ABCB1—Diazepam—epilepsy syndrome	0.00879	0.0283	CbGbCtD
Doxazosin—CYP2C19—Valproic Acid—epilepsy syndrome	0.00859	0.0276	CbGbCtD
Doxazosin—CYP2C19—Topiramate—epilepsy syndrome	0.00775	0.0249	CbGbCtD
Doxazosin—KCNH6—ganglion—epilepsy syndrome	0.00317	0.107	CbGeAlD
Doxazosin—Donepezil—HRH3—epilepsy syndrome	0.00137	0.454	CrCbGaD
Doxazosin—KCNH6—forebrain—epilepsy syndrome	0.00133	0.0449	CbGeAlD
Doxazosin—KCNH6—telencephalon—epilepsy syndrome	0.00122	0.0413	CbGeAlD
Doxazosin—KCNH7—head—epilepsy syndrome	0.00107	0.0361	CbGeAlD
Doxazosin—KCNH7—nervous system—epilepsy syndrome	0.00101	0.0342	CbGeAlD
Doxazosin—KCNH7—central nervous system—epilepsy syndrome	0.000977	0.033	CbGeAlD
Doxazosin—KCNH7—cerebellum—epilepsy syndrome	0.000955	0.0322	CbGeAlD
Doxazosin—KCNH7—brain—epilepsy syndrome	0.000775	0.0262	CbGeAlD
Doxazosin—ADRA1A—hindbrain—epilepsy syndrome	0.000766	0.0258	CbGeAlD
Doxazosin—KCNH6—head—epilepsy syndrome	0.000762	0.0257	CbGeAlD
Doxazosin—ADRA1D—forebrain—epilepsy syndrome	0.000738	0.0249	CbGeAlD
Doxazosin—KCNH6—nervous system—epilepsy syndrome	0.000723	0.0244	CbGeAlD
Doxazosin—KCNH6—central nervous system—epilepsy syndrome	0.000696	0.0235	CbGeAlD
Doxazosin—ADRA1D—telencephalon—epilepsy syndrome	0.000678	0.0229	CbGeAlD
Doxazosin—KCNH6—brain—epilepsy syndrome	0.000553	0.0186	CbGeAlD
Doxazosin—CYP2D6—hindbrain—epilepsy syndrome	0.000451	0.0152	CbGeAlD
Doxazosin—ADRA1A—brainstem—epilepsy syndrome	0.000439	0.0148	CbGeAlD
Doxazosin—ADRA1B—head—epilepsy syndrome	0.000432	0.0146	CbGeAlD
Doxazosin—ADRA1A—forebrain—epilepsy syndrome	0.000424	0.0143	CbGeAlD
Doxazosin—ADRA1D—head—epilepsy syndrome	0.000422	0.0143	CbGeAlD
Doxazosin—ADRA1B—nervous system—epilepsy syndrome	0.000409	0.0138	CbGeAlD
Doxazosin—KCNH2—forebrain—epilepsy syndrome	0.000409	0.0138	CbGeAlD
Doxazosin—ADRA1D—nervous system—epilepsy syndrome	0.0004	0.0135	CbGeAlD
Doxazosin—ADRA1B—central nervous system—epilepsy syndrome	0.000394	0.0133	CbGeAlD
Doxazosin—ORM1—spinal cord—epilepsy syndrome	0.000391	0.0132	CbGeAlD
Doxazosin—ADRA1A—telencephalon—epilepsy syndrome	0.00039	0.0131	CbGeAlD
Doxazosin—ADRA1D—central nervous system—epilepsy syndrome	0.000386	0.013	CbGeAlD
Doxazosin—KCNH2—telencephalon—epilepsy syndrome	0.000376	0.0127	CbGeAlD
Doxazosin—Prazosin—ADRA2A—epilepsy syndrome	0.000366	0.121	CrCbGaD
Doxazosin—Prazosin—ABCG2—epilepsy syndrome	0.000337	0.112	CrCbGaD
Doxazosin—ORM1—nervous system—epilepsy syndrome	0.00033	0.0111	CbGeAlD
Doxazosin—ADRA2A—forebrain—epilepsy syndrome	0.000322	0.0109	CbGeAlD
Doxazosin—ORM1—central nervous system—epilepsy syndrome	0.000318	0.0107	CbGeAlD
Doxazosin—Donepezil—HTR2A—epilepsy syndrome	0.000313	0.104	CrCbGaD
Doxazosin—ADRA1B—brain—epilepsy syndrome	0.000313	0.0106	CbGeAlD
Doxazosin—ADRA1D—brain—epilepsy syndrome	0.000306	0.0103	CbGeAlD
Doxazosin—ADRA2A—telencephalon—epilepsy syndrome	0.000296	0.01	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—epilepsy syndrome	0.000296	0.00998	CbGeAlD
Doxazosin—Donepezil—CYP2D6—epilepsy syndrome	0.000286	0.0949	CrCbGaD
Doxazosin—KCNH2—midbrain—epilepsy syndrome	0.00027	0.00912	CbGeAlD
Doxazosin—KCNH2—spinal cord—epilepsy syndrome	0.000264	0.0089	CbGeAlD
Doxazosin—CYP2D6—brainstem—epilepsy syndrome	0.000259	0.00872	CbGeAlD
Doxazosin—CYP2D6—forebrain—epilepsy syndrome	0.00025	0.00842	CbGeAlD
Doxazosin—ADRA1A—head—epilepsy syndrome	0.000243	0.00819	CbGeAlD
Doxazosin—KCNH2—head—epilepsy syndrome	0.000234	0.00791	CbGeAlD
Doxazosin—ADRA2A—medulla oblongata—epilepsy syndrome	0.000233	0.00785	CbGeAlD
Doxazosin—ADRA1A—nervous system—epilepsy syndrome	0.00023	0.00776	CbGeAlD
Doxazosin—CYP2D6—telencephalon—epilepsy syndrome	0.000229	0.00774	CbGeAlD
Doxazosin—KCNH2—nervous system—epilepsy syndrome	0.000222	0.0075	CbGeAlD
Doxazosin—ADRA1A—central nervous system—epilepsy syndrome	0.000221	0.00747	CbGeAlD
Doxazosin—ADRA1A—cerebellum—epilepsy syndrome	0.000216	0.0073	CbGeAlD
Doxazosin—KCNH2—central nervous system—epilepsy syndrome	0.000214	0.00722	CbGeAlD
Doxazosin—ADRA2A—midbrain—epilepsy syndrome	0.000213	0.00718	CbGeAlD
Doxazosin—KCNH2—cerebellum—epilepsy syndrome	0.000209	0.00705	CbGeAlD
Doxazosin—ADRA2A—spinal cord—epilepsy syndrome	0.000208	0.007	CbGeAlD
Doxazosin—Terazosin—ABCB1—epilepsy syndrome	0.000204	0.0677	CrCbGaD
Doxazosin—ADRA2A—head—epilepsy syndrome	0.000184	0.00622	CbGeAlD
Doxazosin—ABCB1—forebrain—epilepsy syndrome	0.00018	0.00606	CbGeAlD
Doxazosin—ADRA1A—brain—epilepsy syndrome	0.000176	0.00593	CbGeAlD
Doxazosin—ADRA2A—nervous system—epilepsy syndrome	0.000175	0.0059	CbGeAlD
Doxazosin—KCNH2—brain—epilepsy syndrome	0.00017	0.00573	CbGeAlD
Doxazosin—ADRA2A—central nervous system—epilepsy syndrome	0.000168	0.00568	CbGeAlD
Doxazosin—ABCB1—telencephalon—epilepsy syndrome	0.000165	0.00557	CbGeAlD
Doxazosin—ADRA2A—cerebellum—epilepsy syndrome	0.000165	0.00555	CbGeAlD
Doxazosin—CYP2D6—head—epilepsy syndrome	0.000143	0.00482	CbGeAlD
Doxazosin—Prazosin—ABCB1—epilepsy syndrome	0.00014	0.0464	CrCbGaD
Doxazosin—CYP2D6—nervous system—epilepsy syndrome	0.000135	0.00457	CbGeAlD
Doxazosin—ADRA2A—brain—epilepsy syndrome	0.000134	0.00451	CbGeAlD
Doxazosin—CYP2D6—central nervous system—epilepsy syndrome	0.00013	0.0044	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—epilepsy syndrome	0.00013	0.00438	CbGeAlD
Doxazosin—CYP2D6—cerebellum—epilepsy syndrome	0.000127	0.0043	CbGeAlD
Doxazosin—ABCB1—midbrain—epilepsy syndrome	0.000119	0.004	CbGeAlD
Doxazosin—ABCB1—spinal cord—epilepsy syndrome	0.000116	0.0039	CbGeAlD
Doxazosin—CYP2D6—brain—epilepsy syndrome	0.000104	0.00349	CbGeAlD
Doxazosin—ABCB1—head—epilepsy syndrome	0.000103	0.00347	CbGeAlD
Doxazosin—ABCB1—nervous system—epilepsy syndrome	9.74e-05	0.00329	CbGeAlD
Doxazosin—ABCB1—central nervous system—epilepsy syndrome	9.38e-05	0.00317	CbGeAlD
Doxazosin—ABCB1—cerebellum—epilepsy syndrome	9.17e-05	0.00309	CbGeAlD
Doxazosin—ABCB1—brain—epilepsy syndrome	7.45e-05	0.00251	CbGeAlD
Doxazosin—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.18e-05	0.000162	CcSEcCtD
Doxazosin—Vision blurred—Gabapentin—epilepsy syndrome	3.18e-05	0.000161	CcSEcCtD
Doxazosin—Headache—Vigabatrin—epilepsy syndrome	3.17e-05	0.000161	CcSEcCtD
Doxazosin—Hypertension—Pregabalin—epilepsy syndrome	3.17e-05	0.000161	CcSEcCtD
Doxazosin—Vomiting—Diazepam—epilepsy syndrome	3.17e-05	0.000161	CcSEcCtD
Doxazosin—Anorexia—Valproic Acid—epilepsy syndrome	3.16e-05	0.000161	CcSEcCtD
Doxazosin—Tremor—Gabapentin—epilepsy syndrome	3.16e-05	0.00016	CcSEcCtD
Doxazosin—Rash—Diazepam—epilepsy syndrome	3.15e-05	0.00016	CcSEcCtD
Doxazosin—Dermatitis—Diazepam—epilepsy syndrome	3.14e-05	0.00016	CcSEcCtD
Doxazosin—Visual impairment—Topiramate—epilepsy syndrome	3.14e-05	0.000159	CcSEcCtD
Doxazosin—Chest pain—Pregabalin—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Myalgia—Pregabalin—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Arthralgia—Pregabalin—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Dizziness—Zonisamide—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Headache—Diazepam—epilepsy syndrome	3.13e-05	0.000159	CcSEcCtD
Doxazosin—Anxiety—Pregabalin—epilepsy syndrome	3.12e-05	0.000158	CcSEcCtD
Doxazosin—Diarrhoea—Clonazepam—epilepsy syndrome	3.12e-05	0.000158	CcSEcCtD
Doxazosin—Hypotension—Valproic Acid—epilepsy syndrome	3.1e-05	0.000157	CcSEcCtD
Doxazosin—Asthenia—Carbamazepine—epilepsy syndrome	3.1e-05	0.000157	CcSEcCtD
Doxazosin—Agitation—Gabapentin—epilepsy syndrome	3.1e-05	0.000157	CcSEcCtD
Doxazosin—Diarrhoea—Phenytoin—epilepsy syndrome	3.1e-05	0.000157	CcSEcCtD
Doxazosin—Discomfort—Pregabalin—epilepsy syndrome	3.09e-05	0.000157	CcSEcCtD
Doxazosin—Nausea—Fosphenytoin—epilepsy syndrome	3.09e-05	0.000157	CcSEcCtD
Doxazosin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.08e-05	0.000156	CcSEcCtD
Doxazosin—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.08e-05	0.000156	CcSEcCtD
Doxazosin—Vomiting—Felbamate—epilepsy syndrome	3.07e-05	0.000156	CcSEcCtD
Doxazosin—Dry mouth—Pregabalin—epilepsy syndrome	3.06e-05	0.000155	CcSEcCtD
Doxazosin—Pruritus—Carbamazepine—epilepsy syndrome	3.06e-05	0.000155	CcSEcCtD
Doxazosin—Rash—Felbamate—epilepsy syndrome	3.04e-05	0.000155	CcSEcCtD
Doxazosin—Eye disorder—Topiramate—epilepsy syndrome	3.04e-05	0.000155	CcSEcCtD
Doxazosin—Dermatitis—Felbamate—epilepsy syndrome	3.04e-05	0.000155	CcSEcCtD
Doxazosin—Malaise—Gabapentin—epilepsy syndrome	3.04e-05	0.000154	CcSEcCtD
Doxazosin—Tinnitus—Topiramate—epilepsy syndrome	3.04e-05	0.000154	CcSEcCtD
Doxazosin—Vertigo—Gabapentin—epilepsy syndrome	3.03e-05	0.000154	CcSEcCtD
Doxazosin—Headache—Felbamate—epilepsy syndrome	3.02e-05	0.000154	CcSEcCtD
Doxazosin—Confusional state—Pregabalin—epilepsy syndrome	3.02e-05	0.000154	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.02e-05	0.000154	CcSEcCtD
Doxazosin—Flushing—Topiramate—epilepsy syndrome	3.02e-05	0.000154	CcSEcCtD
Doxazosin—Syncope—Gabapentin—epilepsy syndrome	3.02e-05	0.000153	CcSEcCtD
Doxazosin—Leukopenia—Gabapentin—epilepsy syndrome	3.02e-05	0.000153	CcSEcCtD
Doxazosin—Dizziness—Clonazepam—epilepsy syndrome	3.01e-05	0.000153	CcSEcCtD
Doxazosin—Nausea—Vigabatrin—epilepsy syndrome	3.01e-05	0.000153	CcSEcCtD
Doxazosin—Vomiting—Zonisamide—epilepsy syndrome	3.01e-05	0.000153	CcSEcCtD
Doxazosin—Insomnia—Valproic Acid—epilepsy syndrome	3e-05	0.000152	CcSEcCtD
Doxazosin—Oedema—Pregabalin—epilepsy syndrome	3e-05	0.000152	CcSEcCtD
Doxazosin—Asthenia—Lamotrigine—epilepsy syndrome	2.99e-05	0.000152	CcSEcCtD
Doxazosin—Dizziness—Phenytoin—epilepsy syndrome	2.99e-05	0.000152	CcSEcCtD
Doxazosin—Rash—Zonisamide—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Infection—Pregabalin—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Palpitations—Gabapentin—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Dermatitis—Zonisamide—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.98e-05	0.000151	CcSEcCtD
Doxazosin—Nausea—Diazepam—epilepsy syndrome	2.96e-05	0.000151	CcSEcCtD
Doxazosin—Loss of consciousness—Gabapentin—epilepsy syndrome	2.96e-05	0.00015	CcSEcCtD
Doxazosin—Headache—Zonisamide—epilepsy syndrome	2.96e-05	0.00015	CcSEcCtD
Doxazosin—Dyspnoea—Valproic Acid—epilepsy syndrome	2.96e-05	0.00015	CcSEcCtD
Doxazosin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.96e-05	0.00015	CcSEcCtD
Doxazosin—Pruritus—Lamotrigine—epilepsy syndrome	2.95e-05	0.00015	CcSEcCtD
Doxazosin—Shock—Pregabalin—epilepsy syndrome	2.95e-05	0.00015	CcSEcCtD
Doxazosin—Somnolence—Valproic Acid—epilepsy syndrome	2.95e-05	0.00015	CcSEcCtD
Doxazosin—Cough—Gabapentin—epilepsy syndrome	2.94e-05	0.000149	CcSEcCtD
Doxazosin—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.94e-05	0.000149	CcSEcCtD
Doxazosin—Tachycardia—Pregabalin—epilepsy syndrome	2.93e-05	0.000149	CcSEcCtD
Doxazosin—Chills—Topiramate—epilepsy syndrome	2.92e-05	0.000148	CcSEcCtD
Doxazosin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.92e-05	0.000148	CcSEcCtD
Doxazosin—Convulsion—Gabapentin—epilepsy syndrome	2.92e-05	0.000148	CcSEcCtD
Doxazosin—Skin disorder—Pregabalin—epilepsy syndrome	2.91e-05	0.000148	CcSEcCtD
Doxazosin—Hypertension—Gabapentin—epilepsy syndrome	2.91e-05	0.000148	CcSEcCtD
Doxazosin—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.9e-05	0.000147	CcSEcCtD
Doxazosin—Vomiting—Clonazepam—epilepsy syndrome	2.9e-05	0.000147	CcSEcCtD
Doxazosin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.88e-05	0.000146	CcSEcCtD
Doxazosin—Alopecia—Topiramate—epilepsy syndrome	2.88e-05	0.000146	CcSEcCtD
Doxazosin—Vomiting—Phenytoin—epilepsy syndrome	2.88e-05	0.000146	CcSEcCtD
Doxazosin—Rash—Clonazepam—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Dermatitis—Clonazepam—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Chest pain—Gabapentin—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Arthralgia—Gabapentin—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Myalgia—Gabapentin—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Nausea—Felbamate—epilepsy syndrome	2.87e-05	0.000146	CcSEcCtD
Doxazosin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Fatigue—Valproic Acid—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Anxiety—Gabapentin—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Anorexia—Pregabalin—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Dizziness—Carbamazepine—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Doxazosin—Headache—Clonazepam—epilepsy syndrome	2.85e-05	0.000145	CcSEcCtD
Doxazosin—Rash—Phenytoin—epilepsy syndrome	2.85e-05	0.000145	CcSEcCtD
Doxazosin—Mental disorder—Topiramate—epilepsy syndrome	2.85e-05	0.000145	CcSEcCtD
Doxazosin—Dermatitis—Phenytoin—epilepsy syndrome	2.85e-05	0.000145	CcSEcCtD
Doxazosin—Rash—Oxcarbazepine—epilepsy syndrome	2.84e-05	0.000144	CcSEcCtD
Doxazosin—Pain—Valproic Acid—epilepsy syndrome	2.84e-05	0.000144	CcSEcCtD
Doxazosin—Constipation—Valproic Acid—epilepsy syndrome	2.84e-05	0.000144	CcSEcCtD
Doxazosin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.84e-05	0.000144	CcSEcCtD
Doxazosin—Headache—Phenytoin—epilepsy syndrome	2.83e-05	0.000144	CcSEcCtD
Doxazosin—Malnutrition—Topiramate—epilepsy syndrome	2.83e-05	0.000144	CcSEcCtD
Doxazosin—Discomfort—Gabapentin—epilepsy syndrome	2.83e-05	0.000144	CcSEcCtD
Doxazosin—Headache—Oxcarbazepine—epilepsy syndrome	2.82e-05	0.000143	CcSEcCtD
Doxazosin—Nausea—Zonisamide—epilepsy syndrome	2.81e-05	0.000143	CcSEcCtD
Doxazosin—Dry mouth—Gabapentin—epilepsy syndrome	2.81e-05	0.000143	CcSEcCtD
Doxazosin—Hypotension—Pregabalin—epilepsy syndrome	2.8e-05	0.000142	CcSEcCtD
Doxazosin—Flatulence—Topiramate—epilepsy syndrome	2.79e-05	0.000142	CcSEcCtD
Doxazosin—Tension—Topiramate—epilepsy syndrome	2.78e-05	0.000141	CcSEcCtD
Doxazosin—Dysgeusia—Topiramate—epilepsy syndrome	2.78e-05	0.000141	CcSEcCtD
Doxazosin—Confusional state—Gabapentin—epilepsy syndrome	2.77e-05	0.000141	CcSEcCtD
Doxazosin—Dizziness—Lamotrigine—epilepsy syndrome	2.76e-05	0.00014	CcSEcCtD
Doxazosin—Nervousness—Topiramate—epilepsy syndrome	2.75e-05	0.00014	CcSEcCtD
Doxazosin—Oedema—Gabapentin—epilepsy syndrome	2.75e-05	0.00014	CcSEcCtD
Doxazosin—Vomiting—Carbamazepine—epilepsy syndrome	2.75e-05	0.000139	CcSEcCtD
Doxazosin—Back pain—Topiramate—epilepsy syndrome	2.74e-05	0.000139	CcSEcCtD
Doxazosin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.73e-05	0.000139	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.73e-05	0.000139	CcSEcCtD
Doxazosin—Infection—Gabapentin—epilepsy syndrome	2.73e-05	0.000139	CcSEcCtD
Doxazosin—Muscle spasms—Topiramate—epilepsy syndrome	2.73e-05	0.000138	CcSEcCtD
Doxazosin—Rash—Carbamazepine—epilepsy syndrome	2.72e-05	0.000138	CcSEcCtD
Doxazosin—Dermatitis—Carbamazepine—epilepsy syndrome	2.72e-05	0.000138	CcSEcCtD
Doxazosin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.71e-05	0.000138	CcSEcCtD
Doxazosin—Insomnia—Pregabalin—epilepsy syndrome	2.71e-05	0.000138	CcSEcCtD
Doxazosin—Nausea—Clonazepam—epilepsy syndrome	2.71e-05	0.000137	CcSEcCtD
Doxazosin—Headache—Carbamazepine—epilepsy syndrome	2.71e-05	0.000137	CcSEcCtD
Doxazosin—Shock—Gabapentin—epilepsy syndrome	2.71e-05	0.000137	CcSEcCtD
Doxazosin—Paraesthesia—Pregabalin—epilepsy syndrome	2.69e-05	0.000137	CcSEcCtD
Doxazosin—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.69e-05	0.000137	CcSEcCtD
Doxazosin—Nausea—Phenytoin—epilepsy syndrome	2.69e-05	0.000137	CcSEcCtD
Doxazosin—Tachycardia—Gabapentin—epilepsy syndrome	2.68e-05	0.000136	CcSEcCtD
Doxazosin—Dyspnoea—Pregabalin—epilepsy syndrome	2.67e-05	0.000136	CcSEcCtD
Doxazosin—Nausea—Oxcarbazepine—epilepsy syndrome	2.67e-05	0.000136	CcSEcCtD
Doxazosin—Vision blurred—Topiramate—epilepsy syndrome	2.67e-05	0.000136	CcSEcCtD
Doxazosin—Skin disorder—Gabapentin—epilepsy syndrome	2.67e-05	0.000136	CcSEcCtD
Doxazosin—Somnolence—Pregabalin—epilepsy syndrome	2.67e-05	0.000135	CcSEcCtD
Doxazosin—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.66e-05	0.000135	CcSEcCtD
Doxazosin—Tremor—Topiramate—epilepsy syndrome	2.66e-05	0.000135	CcSEcCtD
Doxazosin—Vomiting—Lamotrigine—epilepsy syndrome	2.65e-05	0.000135	CcSEcCtD
Doxazosin—Urticaria—Valproic Acid—epilepsy syndrome	2.64e-05	0.000134	CcSEcCtD
Doxazosin—Rash—Lamotrigine—epilepsy syndrome	2.63e-05	0.000134	CcSEcCtD
Doxazosin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.63e-05	0.000134	CcSEcCtD
Doxazosin—Dermatitis—Lamotrigine—epilepsy syndrome	2.63e-05	0.000134	CcSEcCtD
Doxazosin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Doxazosin—Body temperature increased—Valproic Acid—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Doxazosin—Anorexia—Gabapentin—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Doxazosin—Headache—Lamotrigine—epilepsy syndrome	2.61e-05	0.000133	CcSEcCtD
Doxazosin—Decreased appetite—Pregabalin—epilepsy syndrome	2.61e-05	0.000132	CcSEcCtD
Doxazosin—Agitation—Topiramate—epilepsy syndrome	2.6e-05	0.000132	CcSEcCtD
Doxazosin—Fatigue—Pregabalin—epilepsy syndrome	2.59e-05	0.000131	CcSEcCtD
Doxazosin—Hypotension—Gabapentin—epilepsy syndrome	2.57e-05	0.000131	CcSEcCtD
Doxazosin—Nausea—Carbamazepine—epilepsy syndrome	2.57e-05	0.00013	CcSEcCtD
Doxazosin—Pain—Pregabalin—epilepsy syndrome	2.56e-05	0.00013	CcSEcCtD
Doxazosin—Constipation—Pregabalin—epilepsy syndrome	2.56e-05	0.00013	CcSEcCtD
Doxazosin—Malaise—Topiramate—epilepsy syndrome	2.56e-05	0.00013	CcSEcCtD
Doxazosin—Vertigo—Topiramate—epilepsy syndrome	2.55e-05	0.000129	CcSEcCtD
Doxazosin—Syncope—Topiramate—epilepsy syndrome	2.54e-05	0.000129	CcSEcCtD
Doxazosin—Leukopenia—Topiramate—epilepsy syndrome	2.54e-05	0.000129	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.51e-05	0.000127	CcSEcCtD
Doxazosin—Palpitations—Topiramate—epilepsy syndrome	2.5e-05	0.000127	CcSEcCtD
Doxazosin—Loss of consciousness—Topiramate—epilepsy syndrome	2.49e-05	0.000127	CcSEcCtD
Doxazosin—Insomnia—Gabapentin—epilepsy syndrome	2.49e-05	0.000126	CcSEcCtD
Doxazosin—Nausea—Lamotrigine—epilepsy syndrome	2.48e-05	0.000126	CcSEcCtD
Doxazosin—Cough—Topiramate—epilepsy syndrome	2.47e-05	0.000126	CcSEcCtD
Doxazosin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.47e-05	0.000126	CcSEcCtD
Doxazosin—Paraesthesia—Gabapentin—epilepsy syndrome	2.47e-05	0.000125	CcSEcCtD
Doxazosin—Convulsion—Topiramate—epilepsy syndrome	2.46e-05	0.000125	CcSEcCtD
Doxazosin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.45e-05	0.000125	CcSEcCtD
Doxazosin—Dyspnoea—Gabapentin—epilepsy syndrome	2.45e-05	0.000125	CcSEcCtD
Doxazosin—Hypertension—Topiramate—epilepsy syndrome	2.45e-05	0.000124	CcSEcCtD
Doxazosin—Somnolence—Gabapentin—epilepsy syndrome	2.44e-05	0.000124	CcSEcCtD
Doxazosin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.44e-05	0.000124	CcSEcCtD
Doxazosin—Dyspepsia—Gabapentin—epilepsy syndrome	2.42e-05	0.000123	CcSEcCtD
Doxazosin—Myalgia—Topiramate—epilepsy syndrome	2.41e-05	0.000123	CcSEcCtD
Doxazosin—Chest pain—Topiramate—epilepsy syndrome	2.41e-05	0.000123	CcSEcCtD
Doxazosin—Arthralgia—Topiramate—epilepsy syndrome	2.41e-05	0.000123	CcSEcCtD
Doxazosin—Anxiety—Topiramate—epilepsy syndrome	2.4e-05	0.000122	CcSEcCtD
Doxazosin—Decreased appetite—Gabapentin—epilepsy syndrome	2.39e-05	0.000121	CcSEcCtD
Doxazosin—Discomfort—Topiramate—epilepsy syndrome	2.38e-05	0.000121	CcSEcCtD
Doxazosin—Urticaria—Pregabalin—epilepsy syndrome	2.38e-05	0.000121	CcSEcCtD
Doxazosin—Asthenia—Valproic Acid—epilepsy syndrome	2.38e-05	0.000121	CcSEcCtD
Doxazosin—Fatigue—Gabapentin—epilepsy syndrome	2.37e-05	0.00012	CcSEcCtD
Doxazosin—Abdominal pain—Pregabalin—epilepsy syndrome	2.37e-05	0.00012	CcSEcCtD
Doxazosin—Body temperature increased—Pregabalin—epilepsy syndrome	2.37e-05	0.00012	CcSEcCtD
Doxazosin—Dry mouth—Topiramate—epilepsy syndrome	2.36e-05	0.00012	CcSEcCtD
Doxazosin—Pain—Gabapentin—epilepsy syndrome	2.35e-05	0.000119	CcSEcCtD
Doxazosin—Constipation—Gabapentin—epilepsy syndrome	2.35e-05	0.000119	CcSEcCtD
Doxazosin—Pruritus—Valproic Acid—epilepsy syndrome	2.35e-05	0.000119	CcSEcCtD
Doxazosin—Confusional state—Topiramate—epilepsy syndrome	2.33e-05	0.000118	CcSEcCtD
Doxazosin—Oedema—Topiramate—epilepsy syndrome	2.31e-05	0.000118	CcSEcCtD
Doxazosin—Infection—Topiramate—epilepsy syndrome	2.3e-05	0.000117	CcSEcCtD
Doxazosin—Shock—Topiramate—epilepsy syndrome	2.28e-05	0.000116	CcSEcCtD
Doxazosin—Diarrhoea—Valproic Acid—epilepsy syndrome	2.27e-05	0.000115	CcSEcCtD
Doxazosin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.27e-05	0.000115	CcSEcCtD
Doxazosin—Thrombocytopenia—Topiramate—epilepsy syndrome	2.27e-05	0.000115	CcSEcCtD
Doxazosin—Tachycardia—Topiramate—epilepsy syndrome	2.26e-05	0.000115	CcSEcCtD
Doxazosin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.25e-05	0.000114	CcSEcCtD
Doxazosin—Skin disorder—Topiramate—epilepsy syndrome	2.25e-05	0.000114	CcSEcCtD
Doxazosin—Hyperhidrosis—Topiramate—epilepsy syndrome	2.24e-05	0.000114	CcSEcCtD
Doxazosin—Hypersensitivity—Pregabalin—epilepsy syndrome	2.21e-05	0.000112	CcSEcCtD
Doxazosin—Anorexia—Topiramate—epilepsy syndrome	2.21e-05	0.000112	CcSEcCtD
Doxazosin—Dizziness—Valproic Acid—epilepsy syndrome	2.19e-05	0.000111	CcSEcCtD
Doxazosin—Urticaria—Gabapentin—epilepsy syndrome	2.18e-05	0.000111	CcSEcCtD
Doxazosin—Abdominal pain—Gabapentin—epilepsy syndrome	2.17e-05	0.00011	CcSEcCtD
Doxazosin—Body temperature increased—Gabapentin—epilepsy syndrome	2.17e-05	0.00011	CcSEcCtD
Doxazosin—Hypotension—Topiramate—epilepsy syndrome	2.16e-05	0.00011	CcSEcCtD
Doxazosin—Asthenia—Pregabalin—epilepsy syndrome	2.15e-05	0.000109	CcSEcCtD
Doxazosin—Pruritus—Pregabalin—epilepsy syndrome	2.12e-05	0.000108	CcSEcCtD
Doxazosin—Vomiting—Valproic Acid—epilepsy syndrome	2.11e-05	0.000107	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.11e-05	0.000107	CcSEcCtD
Doxazosin—Insomnia—Topiramate—epilepsy syndrome	2.09e-05	0.000106	CcSEcCtD
Doxazosin—Rash—Valproic Acid—epilepsy syndrome	2.09e-05	0.000106	CcSEcCtD
Doxazosin—Dermatitis—Valproic Acid—epilepsy syndrome	2.09e-05	0.000106	CcSEcCtD
Doxazosin—Headache—Valproic Acid—epilepsy syndrome	2.08e-05	0.000106	CcSEcCtD
Doxazosin—Paraesthesia—Topiramate—epilepsy syndrome	2.08e-05	0.000106	CcSEcCtD
Doxazosin—Dyspnoea—Topiramate—epilepsy syndrome	2.06e-05	0.000105	CcSEcCtD
Doxazosin—Somnolence—Topiramate—epilepsy syndrome	2.06e-05	0.000104	CcSEcCtD
Doxazosin—Diarrhoea—Pregabalin—epilepsy syndrome	2.05e-05	0.000104	CcSEcCtD
Doxazosin—Dyspepsia—Topiramate—epilepsy syndrome	2.04e-05	0.000103	CcSEcCtD
Doxazosin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.03e-05	0.000103	CcSEcCtD
Doxazosin—Decreased appetite—Topiramate—epilepsy syndrome	2.01e-05	0.000102	CcSEcCtD
Doxazosin—Fatigue—Topiramate—epilepsy syndrome	1.99e-05	0.000101	CcSEcCtD
Doxazosin—Dizziness—Pregabalin—epilepsy syndrome	1.98e-05	0.000101	CcSEcCtD
Doxazosin—Pain—Topiramate—epilepsy syndrome	1.98e-05	0.0001	CcSEcCtD
Doxazosin—Constipation—Topiramate—epilepsy syndrome	1.98e-05	0.0001	CcSEcCtD
Doxazosin—Asthenia—Gabapentin—epilepsy syndrome	1.97e-05	0.0001	CcSEcCtD
Doxazosin—Nausea—Valproic Acid—epilepsy syndrome	1.97e-05	0.0001	CcSEcCtD
Doxazosin—Pruritus—Gabapentin—epilepsy syndrome	1.95e-05	9.88e-05	CcSEcCtD
Doxazosin—Vomiting—Pregabalin—epilepsy syndrome	1.91e-05	9.69e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Topiramate—epilepsy syndrome	1.91e-05	9.68e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.89e-05	9.61e-05	CcSEcCtD
Doxazosin—Rash—Pregabalin—epilepsy syndrome	1.89e-05	9.6e-05	CcSEcCtD
Doxazosin—Dermatitis—Pregabalin—epilepsy syndrome	1.89e-05	9.6e-05	CcSEcCtD
Doxazosin—Diarrhoea—Gabapentin—epilepsy syndrome	1.88e-05	9.56e-05	CcSEcCtD
Doxazosin—Headache—Pregabalin—epilepsy syndrome	1.88e-05	9.54e-05	CcSEcCtD
Doxazosin—Urticaria—Topiramate—epilepsy syndrome	1.84e-05	9.34e-05	CcSEcCtD
Doxazosin—Abdominal pain—Topiramate—epilepsy syndrome	1.83e-05	9.29e-05	CcSEcCtD
Doxazosin—Body temperature increased—Topiramate—epilepsy syndrome	1.83e-05	9.29e-05	CcSEcCtD
Doxazosin—Dizziness—Gabapentin—epilepsy syndrome	1.82e-05	9.24e-05	CcSEcCtD
Doxazosin—Nausea—Pregabalin—epilepsy syndrome	1.78e-05	9.05e-05	CcSEcCtD
Doxazosin—Vomiting—Gabapentin—epilepsy syndrome	1.75e-05	8.88e-05	CcSEcCtD
Doxazosin—Rash—Gabapentin—epilepsy syndrome	1.73e-05	8.81e-05	CcSEcCtD
Doxazosin—Dermatitis—Gabapentin—epilepsy syndrome	1.73e-05	8.8e-05	CcSEcCtD
Doxazosin—Headache—Gabapentin—epilepsy syndrome	1.72e-05	8.75e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Topiramate—epilepsy syndrome	1.7e-05	8.66e-05	CcSEcCtD
Doxazosin—Asthenia—Topiramate—epilepsy syndrome	1.66e-05	8.43e-05	CcSEcCtD
Doxazosin—Pruritus—Topiramate—epilepsy syndrome	1.64e-05	8.31e-05	CcSEcCtD
Doxazosin—Nausea—Gabapentin—epilepsy syndrome	1.63e-05	8.3e-05	CcSEcCtD
Doxazosin—Diarrhoea—Topiramate—epilepsy syndrome	1.58e-05	8.04e-05	CcSEcCtD
Doxazosin—Dizziness—Topiramate—epilepsy syndrome	1.53e-05	7.77e-05	CcSEcCtD
Doxazosin—Vomiting—Topiramate—epilepsy syndrome	1.47e-05	7.47e-05	CcSEcCtD
Doxazosin—Rash—Topiramate—epilepsy syndrome	1.46e-05	7.41e-05	CcSEcCtD
Doxazosin—Dermatitis—Topiramate—epilepsy syndrome	1.46e-05	7.4e-05	CcSEcCtD
Doxazosin—Headache—Topiramate—epilepsy syndrome	1.45e-05	7.36e-05	CcSEcCtD
Doxazosin—Nausea—Topiramate—epilepsy syndrome	1.37e-05	6.98e-05	CcSEcCtD
Doxazosin—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	3.46e-06	3.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	3.46e-06	3.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	3.46e-06	3.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	3.46e-06	3.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	3.44e-06	3.17e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TH—epilepsy syndrome	3.43e-06	3.16e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	3.42e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	3.42e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	3.41e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	3.37e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	3.37e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	3.37e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	3.34e-06	3.08e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	3.34e-06	3.07e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	3.32e-06	3.05e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	3.3e-06	3.04e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	3.28e-06	3.02e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HES1—epilepsy syndrome	3.28e-06	3.01e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	3.25e-06	3e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	3.23e-06	2.98e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.23e-06	2.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	3.22e-06	2.96e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	3.22e-06	2.96e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FYN—epilepsy syndrome	3.19e-06	2.93e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	3.18e-06	2.93e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—H2AFX—epilepsy syndrome	3.17e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	3.17e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	3.17e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	3.17e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MEF2C—epilepsy syndrome	3.17e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	3.16e-06	2.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	3.16e-06	2.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	3.15e-06	2.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	3.14e-06	2.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	3.13e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	3.13e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	3.13e-06	2.88e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.12e-06	2.87e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	3.11e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	3.11e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	3.1e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	3.1e-06	2.85e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	3.06e-06	2.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	3.05e-06	2.81e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.04e-06	2.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	3.03e-06	2.79e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	3.03e-06	2.79e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.02e-06	2.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	3.01e-06	2.77e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SRC—epilepsy syndrome	3e-06	2.76e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3e-06	2.76e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	2.98e-06	2.74e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	2.97e-06	2.73e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.97e-06	2.73e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.95e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	2.95e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.95e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.94e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.94e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.94e-06	2.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.93e-06	2.7e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.92e-06	2.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.92e-06	2.69e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	2.89e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.89e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.89e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	2.88e-06	2.65e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.88e-06	2.65e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	2.87e-06	2.65e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	2.87e-06	2.64e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.87e-06	2.64e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.86e-06	2.64e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.83e-06	2.6e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.82e-06	2.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.82e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.81e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.81e-06	2.59e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.8e-06	2.57e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.78e-06	2.56e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	2.53e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	2.74e-06	2.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.74e-06	2.52e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.73e-06	2.52e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	2.73e-06	2.52e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.73e-06	2.51e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	2.72e-06	2.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	2.69e-06	2.47e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	2.68e-06	2.47e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	2.67e-06	2.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	2.67e-06	2.46e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.66e-06	2.45e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.64e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	2.64e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	2.64e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	2.63e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	2.63e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	2.63e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	2.62e-06	2.41e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	2.61e-06	2.4e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.6e-06	2.39e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.59e-06	2.38e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX1—epilepsy syndrome	2.55e-06	2.35e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	2.55e-06	2.35e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	2.54e-06	2.34e-05	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.54e-06	2.34e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.53e-06	2.33e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	2.53e-06	2.33e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.52e-06	2.32e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	2.52e-06	2.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	2.48e-06	2.28e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.47e-06	2.27e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	2.46e-06	2.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	2.45e-06	2.26e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	2.44e-06	2.25e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.44e-06	2.25e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TH—epilepsy syndrome	2.43e-06	2.24e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	2.41e-06	2.22e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.41e-06	2.22e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.39e-06	2.2e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	2.39e-06	2.2e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.39e-06	2.2e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.38e-06	2.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.38e-06	2.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	2.37e-06	2.18e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TH—epilepsy syndrome	2.37e-06	2.18e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	2.35e-06	2.16e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.34e-06	2.15e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.34e-06	2.15e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	2.3e-06	2.12e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	2.27e-06	2.09e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	2.27e-06	2.09e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.27e-06	2.09e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.26e-06	2.08e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	2.25e-06	2.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	2.24e-06	2.07e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.24e-06	2.06e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AGT—epilepsy syndrome	2.24e-06	2.06e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TH—epilepsy syndrome	2.24e-06	2.06e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	2.23e-06	2.05e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	2.22e-06	2.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—epilepsy syndrome	2.2e-06	2.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	2.18e-06	2.01e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	2.18e-06	2.01e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.17e-06	2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	2.17e-06	2e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.17e-06	2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.12e-06	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.1e-06	1.93e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.1e-06	1.93e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.09e-06	1.92e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.07e-06	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	2.04e-06	1.87e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.03e-06	1.87e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	2.02e-06	1.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.02e-06	1.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	2.02e-06	1.86e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAT—epilepsy syndrome	2e-06	1.84e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.98e-06	1.82e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.98e-06	1.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.97e-06	1.82e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAT—epilepsy syndrome	1.95e-06	1.8e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.95e-06	1.79e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.94e-06	1.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.91e-06	1.76e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.89e-06	1.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.89e-06	1.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.88e-06	1.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.87e-06	1.72e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.87e-06	1.72e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.87e-06	1.72e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.86e-06	1.72e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.86e-06	1.71e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.86e-06	1.71e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.85e-06	1.71e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.84e-06	1.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.84e-06	1.69e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.81e-06	1.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.8e-06	1.66e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.79e-06	1.65e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.77e-06	1.63e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.73e-06	1.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.72e-06	1.59e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.72e-06	1.58e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.72e-06	1.58e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	1.57e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.7e-06	1.56e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.69e-06	1.55e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.66e-06	1.53e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.66e-06	1.53e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.66e-06	1.52e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.61e-06	1.48e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.59e-06	1.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.58e-06	1.45e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.57e-06	1.44e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.56e-06	1.44e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.56e-06	1.43e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.55e-06	1.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.54e-06	1.42e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.54e-06	1.42e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.52e-06	1.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	1.38e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.5e-06	1.38e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	1.37e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.46e-06	1.34e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.45e-06	1.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.43e-06	1.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.43e-06	1.31e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.41e-06	1.3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.39e-06	1.28e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.39e-06	1.28e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.37e-06	1.26e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.37e-06	1.26e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.34e-06	1.23e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.34e-06	1.23e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.3e-06	1.2e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.3e-06	1.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.29e-06	1.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.27e-06	1.17e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.27e-06	1.17e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.26e-06	1.16e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.23e-06	1.13e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.23e-06	1.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	1.22e-06	1.12e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.22e-06	1.12e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.2e-06	1.1e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.19e-06	1.09e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-06	1.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.18e-06	1.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.17e-06	1.07e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.15e-06	1.06e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.13e-06	1.04e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.12e-06	1.03e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.1e-06	1.02e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	1.09e-06	1.01e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.07e-06	9.85e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-06	9.81e-06	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.07e-06	9.81e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.04e-06	9.57e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.02e-06	9.36e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	9.91e-07	9.12e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	9.8e-07	9.02e-06	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	9.23e-07	8.49e-06	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	7.66e-07	7.05e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—epilepsy syndrome	7.56e-07	6.96e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	6.8e-07	6.26e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	6.32e-07	5.82e-06	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.36e-07	4.93e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.23e-07	4.81e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.93e-07	4.53e-06	CbGpPWpGaD
